Cat.#: ACPP-1826
Despition | CRYGN Human Recombinant |
SIZE | 5 µg |
Purity | > 90% (SDS-PAGE) |
Form | Sterile Filtered colorless solution. |
Storage | Store at 4°C for 2-4 weeks. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
ACPP-1834 | Human BAALC Protein (AC1834) | 2 µg | inquiry |
ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
ACPP-1144 | Synthetic Nanodisc Human GIPR Protein (AC1144) | 10 µg | inquiry |
ACPP-1111 | Recombinant Human NRG1 Protein (Fc Tag) (AC1111) | 50 µg | inquiry |
ACPP-1161 | Recombinant Human DLK-1 Protein (6×His Tag) (AC1161) | 50 µg | inquiry |
ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg | inquiry |
ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
ACPP-1581 | Rat FGF 9 Protein (AC1581) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.